Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Statement

26 Jun 2024 07:00

RNS Number : 8638T
PZ CUSSONS PLC
26 June 2024
 

26 June 2024

Trading Statement

 

PZ Cussons plc ("PZ Cussons" or the "Group") announces that trading in the final quarter of the financial year, which ended on 31 May, was in line with management expectations.

 

The Group expects to report FY24 revenue of approximately £528 million. Despite a 23% adverse movement in the value of the Nigerian Naira since our Q3 trading update in April [1], the Group expects to report adjusted operating profit in the region of £55-60 million, in line with previous guidance. Gross debt as at 31 May 2024 is also expected to be comfortably within the guided range of £160-180 million. Surplus cash in Nigeria is minimal as a result of prioritising the continued repatriation of cash.

 

On 24 April 2024 the Group announced its plan to maximise shareholder value from a portfolio transformation, following a strategic review of brands and geographies. An update will be provided when appropriate.

 

The Group will report full year results on 18 September.

 

[1] NGN/GBP rate of 1,893 as at 31 May compared to a rate of approximately 1,450 on 24 April

Contact details

Investors 

Simon Whittington - IR and Corporate Development Director

+44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com

+44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

 Notes to Editors

Summary of foreign exchange rates used

The Naira has devalued by approximately 70% as at 31 May 2024 compared to 31 May 2023, as shown below.

NGN/GBP

FY23

FY24

Rate used for P&L

536

1,257

Rate used for balance sheet

577

1,893

 

About PZ Cussons

PZ Cussons is a FTSE 250 listed consumer goods business headquartered in Manchester, UK. We employ over 2,600 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.

Cautionary note regarding forward-looking statements

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand, along with risks associated with macroeconomic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as of the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the PZ Cussons Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The PZ Cussons Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward-looking statements contained within this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVAKRSUUNUAR
Date   Source Headline
1st Apr 201011:21 amRNSDirector/PDMR Shareholding
25th Mar 20104:51 pmRNSDirector/PDMR Shareholding
19th Feb 201010:42 amRNSDirector/PDMR Shareholding
3rd Feb 20106:00 pmRNSDirector/PDMR Shareholding
26th Jan 20107:00 amRNSHalf Yearly Report
9th Dec 20097:00 amRNSTrading Update
26th Nov 20097:00 amRNSAppointment of Richard Harvey as Chairman-elect
20th Oct 20095:15 pmRNSHolding(s) in Company
19th Oct 20094:27 pmRNSDirector/PDMR Shareholding
6th Oct 20095:57 pmRNSResult of AGM
5th Oct 20097:00 amRNSInterim Management Statement
18th Sep 20097:00 amRNSAnnual Information Update
3rd Sep 20093:15 pmRNSDirector/PDMR Shareholding
25th Aug 20098:00 amRNSAnnual Financial Report
17th Aug 20097:00 amRNSDirector/PDMR Shareholding
31st Jul 20091:17 pmRNSDirector/PDMR Shareholding
30th Jul 20096:00 pmRNSDirector/PDMR Shareholding
28th Jul 20097:00 amRNSFinal Results
9th Jul 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20097:00 amRNSTrading Update
2nd Jun 20099:11 amRNSNotice of Trading Update and Preliminary Results
8th Apr 20097:00 amRNSInterim Management Statement
13th Feb 20094:32 pmRNSDirector/PDMR Shareholding
27th Jan 20097:00 amRNSHalf Yearly Report
9th Dec 20087:00 amRNSTrading Statement
27th Nov 20084:36 pmRNSPrice Monitoring Extension
12th Nov 20082:19 pmRNSDirector/PDMR Shareholding
3rd Nov 200812:07 pmRNSDirector/PDMR Shareholding
6th Oct 20087:00 amRNSNotice of Trading Update
2nd Oct 20084:47 pmRNSDirector/PDMR Shareholding
29th Sep 20087:00 amRNSInterim Management Statement
18th Sep 20087:00 amRNSAppointment of Joint Broker
17th Sep 20087:00 amRNSAnnual Information Update
29th Jul 20087:00 amRNSFinal Results
5th Jun 20087:00 amRNSTrading Update
14th Apr 200812:30 pmRNSDirector/PDMR Shareholding
8th Apr 20087:00 amRNSInterim Management Statement
11th Mar 20089:05 amRNSPurchased Shares
29th Jan 20087:01 amRNSAcquisition
29th Jan 20087:01 amRNSInterim Results
3rd Jan 200810:35 amRNSDirector Declaration
6th Dec 20077:00 amRNSTrading Statement
19th Nov 20072:04 pmRNSDirectorate Change
16th Oct 20079:33 amRNSDirector/PDMR Shareholding
12th Oct 200710:58 amRNSDirector/PDMR Shareholding
10th Oct 20072:59 pmRNSDirector/PDMR Shareholding
24th Sep 20077:01 amRNSInterim Management Statement
20th Sep 20077:01 amRNSAnnual Information Update
8th Aug 20074:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20076:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.